First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2012
|
| Online Access: | http://hdl.handle.net/20.500.11937/17432 |
| _version_ | 1848749465046876160 |
|---|---|
| author | Bergh, J. Bondarenko, I. Lichinitser, M. Liljegren, A. Greil, R. Voytko, N. Makhson, A. Cortes, J. Lortholary, A. Bischoff, J. Chan, Arlene Delaloge, S. Huang, X. Kern, K. Giorgetti, C. |
| author_facet | Bergh, J. Bondarenko, I. Lichinitser, M. Liljegren, A. Greil, R. Voytko, N. Makhson, A. Cortes, J. Lortholary, A. Bischoff, J. Chan, Arlene Delaloge, S. Huang, X. Kern, K. Giorgetti, C. |
| author_sort | Bergh, J. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| first_indexed | 2025-11-14T07:21:22Z |
| format | Journal Article |
| id | curtin-20.500.11937-17432 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T07:21:22Z |
| publishDate | 2012 |
| publisher | American Society of Clinical Oncology |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-174322017-05-30T07:59:52Z First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study Bergh, J. Bondarenko, I. Lichinitser, M. Liljegren, A. Greil, R. Voytko, N. Makhson, A. Cortes, J. Lortholary, A. Bischoff, J. Chan, Arlene Delaloge, S. Huang, X. Kern, K. Giorgetti, C. 2012 Journal Article http://hdl.handle.net/20.500.11937/17432 American Society of Clinical Oncology restricted |
| spellingShingle | Bergh, J. Bondarenko, I. Lichinitser, M. Liljegren, A. Greil, R. Voytko, N. Makhson, A. Cortes, J. Lortholary, A. Bischoff, J. Chan, Arlene Delaloge, S. Huang, X. Kern, K. Giorgetti, C. First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study |
| title | First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study |
| title_full | First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study |
| title_fullStr | First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study |
| title_full_unstemmed | First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study |
| title_short | First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study |
| title_sort | first-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase iii study |
| url | http://hdl.handle.net/20.500.11937/17432 |